Integration of external laboratory test results without careful review could lead to significant patient safety issues, particularly as we move towards ever increasing usages of clinical decision support. These interoperability issues preclude artificial intelligence (AI) from reaching its potential, and instead introduce new risks pathologists need to be cognizant of, explains Monica de Baca, MD, FCAP. in this CAPcast interview. Dr. de Baca is moderating a panel discussion on this topic at the Pathologists Leadership Summit, which will be held virtually and in person in Washington, DC from April 30-May 3.

The title of this panel discussion is "Towards Laboratory Data Democratization and Artificial Intelligence: Underlying Standards and What Pathologists Need to Know" and will be held on Sunday May 1, from 3:00-4:00 pm EST. For more information, please visit pathologistsleadershipsummit.org.